Literature DB >> 16701011

Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.

You-peng Chen1, Thiemo Pfab, Torsten Slowinski, Claus-Michael Richter, Michael Godes, Berthold Hocher.   

Abstract

BACKGROUND: The mechanisms responsible for the pathogeneses of gestational hypertension and preeclampsia are unclear. Tumor necrosis factor-alpha (TNF-alpha) is a pro-inflammatory Th(1)-type cytokine. TNFA gene is located in the human leukocyte antigen (HLA) class III region of the major histocompatibility complex (MHC) on chromosome 6. The high TNF-alpha mRNA expression may be associated with the TNF2 (A) allele, which is the polymorphism of TNF-alpha at position -308 in promoter region. This study assessed whether the TNF2 (A) allele at position -308 plays a role in the alteration of blood pressure (BP) and urinary protein excretion during pregnancy.
METHODS: The original prospective cohort study comprised 1623 pregnant women from January 2000 to October 2001. The G/A polymorphism was done by restriction fragment length polymorphism (RFLP) analysis with Nco I enzyme.
RESULTS: The distributions of the G/A polymorphism of TNF-alpha in the promoter region at position -308 were wild-type 72.4% and variant 27.6%, respectively. The frequency of TNF2 (A) allele was approximately 0.15 for Caucasian pregnant women in the study. It was not significantly different in the distributions of genotypes and G/A allele frequencies among the three groups of pregnant women with gestational hypertension, preexisting hypertension and normal blood pressure (P > 0.05). The maternal blood pressure in the third trimester was significantly higher in the group of women possessing the TNF2 (A) allele compared to homozygous for the TNF1 (G) allele (systolic BP, P < 0.01 and diastolic BP, P < 0.05). The elevated blood pressure in the TNF2 (A) group was accompanied by higher urinary protein excretion in the third trimester (P < 0.05). The blood pressure and urinary protein excretion did not change apparently between the two groups in the first and second trimesters (P > 0.05).
CONCLUSIONS: Maternal TNF2 (A) allele of TNF-alpha promoter region at position -308 could play a role in the alteration of blood pressures and/or enhancement of urinary protein excretion during pregnancy, and might play an important role in the development of both gestational hypertension and preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16701011

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Assessment of biochemical parameters and characterization of TNFα -308G/A and PTPN22 +1858C/T gene polymorphisms in the risk of obesity in adolescents.

Authors:  Mauricio Andrés Salinas-Santander; Rafael Baltazar León-Cachón; Ana Cecilia Cepeda-Nieto; Celia Nohemí Sánchez-Domínguez; María Antonia González-Zavala; Hugo Leonid Gallardo-Blanco; Sandra Cecilia Esparza-González; Miguel Ángel González-Madrazo
Journal:  Biomed Rep       Date:  2015-10-27

2.  Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNFalpha with pre-eclampsia in Chinese women.

Authors:  Lu Zhou; Li Cheng; Yun He; Yin Gu; Yejun Wang; Chenhong Wang
Journal:  Inflamm Res       Date:  2016-05-27       Impact factor: 4.575

3.  Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population.

Authors:  Mauricio Salinas-Santander; Daniel Díaz-García; Augusto Rojas-Martínez; Cristina Cantú-Salinas; Celia Sánchez-Domínguez; Miguel Reyes-López; Ricardo M Cerda-Flores; Jorge Ocampo-Candiani; Rocío Ortiz-López
Journal:  Exp Ther Med       Date:  2012-03-09       Impact factor: 2.447

4.  The tumor necrosis factor α (-308 A/G) polymorphism is associated with cystic fibrosis in Mexican patients.

Authors:  Celia N Sanchez-Dominguez; Miguel A Reyes-Lopez; Adriana Bustamante; Ricardo M Cerda-Flores; Maria Del C Villalobos-Torres; Hugo L Gallardo-Blanco; Augusto Rojas-Martinez; Herminia G Martinez-Rodriguez; Hugo A Barrera-Saldaña; Rocio Ortiz-Lopez
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

5.  The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction.

Authors:  Agata Bielecka-Dabrowa; Agata Sakowicz; Tadeusz Pietrucha; Małgorzata Misztal; Piotr Chruściel; Jacek Rysz; Maciej Banach
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.